Search for Clinical Trial Results
Craniopharyngioma - 1 Studies Found
| Status | Study |
| RECRUITING |
Study Name: MEKTOVI� for the Treatment of Pediatric Adamantinomatous Craniopharyngioma Condition: Adamantinous Craniopharyngioma Date: 2024-10-13 Interventions: Binimetinib oral continuous dosing 32 mg/m2 PO BID for 4 weeks |